Document is current
Any future updates will be listed below
-
Authors
,
Katz, Matthew H. G.
Ou, Fang-Shu
Herman, Joseph M.
Ahmad, Syed A.
Wolpin, Brian
Marsh, Robert
Behr, Spencer
Shi, Qian
Chuong, Michael
Schwartz, Lawrence H.
Frankel, Wendy
Collisson, Eric
Koay, Eugene J.
Hubbard, JoLeen M.
Leenstra, James L.
Meyerhardt, Jeffrey
O’Reilly, Eileen
-
Funding
Funding for this research was provided by:
National Institutes of Health (U10CA180821)
National Institutes of Health (U10CA180882)
- License Information
-
More Information
Article History
Received: 10 February 2017
Accepted: 21 June 2017
First Online: 27 July 2017
Authors’ information
: None.
: This study was approved by the Protocol Review Committee of the Cancer Therapy Evaluation Program (CTEP) at the National Institutes of Health National Cancer Institute (Reference Number PA021501_R02PAPP02). The study is approved by each participating institution’s Institutional Review Board.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
